MassMutual Private Wealth & Trust’s CorMedix CRMD Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.95K	Sell	630 -35	-5%	-$277	﹤0.01%	1687
2026 Q1	$4.51K	Buy	665 +249	+60%	+$1.84K	﹤0.01%	1719
2025 Q4	$4.84K	Sell	416 -84	-17%	-$929	﹤0.01%	1685
2025 Q3	$5.82K	Buy	500 +212	+74%	+$2.56K	﹤0.01%	1610
2025 Q2	$3.55K	Hold	288	–	–	﹤0.01%	1764
2025 Q1	$1.77K	Buy	+288	New	+$2.98K	﹤0.01%	1954
2023 Q4	–	Sell	-250	Closed	-$925	–	1977
2023 Q3	$925	Buy	+250	New	+$994	﹤0.01%	1711

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

MassMutual Private Wealth & Trust's CRMD Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its CorMedix (CRMD) stake by 5.3% in Q2 2026, selling an estimated $277 and leaving 630 shares worth $4.95K. The position accounts for ﹤0.01% of the portfolio, ranked #1687.

MassMutual Private Wealth & Trust first reported a position in CRMD in Q3 2023 and has held it in 7 quarters since. The position peaked at $5.82K in Q3 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

MassMutual Private Wealth & Trust held 630 shares of CorMedix worth $4.95K as of Q2 2026.
MassMutual Private Wealth & Trust sold 35 CorMedix shares in Q2 2026, an estimated $277.
CorMedix made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1687 holding.
MassMutual Private Wealth & Trust first reported a position in CorMedix in Q3 2023 and has held it in 7 quarters since.
MassMutual Private Wealth & Trust's CorMedix position peaked at $5.82K in Q3 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.